SCM
RACB

Silverarc Capital Management’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Silverarc Capital Management’s Portfolio RACB Stock Details RACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-556,890
Closed -$5.42M – 89
2021
Q4 		$5.42M Buy
556,890
+83,494
+18% +$821K 2.43% 15
2021
Q3 		$4.66M Sell
473,396
-22,459
-5% -$222K 2.7% 12
2021
Q2 		$5.03K Sell
495,855
-4,145
-0.8% -$43.7K 2.45% 12
2021
Q1 		$5.13M Buy
+500,000
New +$5.12M 2.87% 7

Other funds holding RACB

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return